• $111.2M
    Market Cap
  • -99.09%
    1-Year Change
  • Asset Management
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 61
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke

Helius Medical Technologies filed a 510(k) submission to the FDA seeking expanded indication for its PoNS device to treat gait and balance deficits in chronic stroke patients, based on clinical trials demonstrating statistically significant improvements in functional gait assessment.

09/25/2025, 7:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$1.46
$1.59
$1.48
1-Year Range
$0.18
$24.13
$1.48
Latest Close$1.48
Change
-$0.12 (-8.11%)
Volume571,601
Market Cap$111.2M
Shares Outstanding58.4M
P/E (TTM)-0.55
Diluted EPS (TTM)-$3.49
Enterprise Value$106.8M

Information as of 06/03/2026

Company Profile

$111.2M
Market Cap
-$136.9M
Net Income
Sector: Financial Services
Industry: Asset Management
642 Newtown Yardley Road, Newtown, PA, United States, 18940
215 944 6100

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.

Key Executives

  • Dane Carl Andreeff
  • Jeffrey S. Mathiesen
  • Antonella Favit-Van Pelt
  • Choon Wee Chee
  • Agustina Gani Tjandrasuwita

Current Ownership Distribution

  • Institutions28.8M (49.40%)
  • Other15.1M (25.87%)
  • Mutual Funds8.4M (14.30%)
  • Insiders6.1M (10.42%)